Immunology, Serology and Blood Banking Flashcards

1
Q

antibody heterogeneity: variations between light and heavy chains; constant regions of all antibodies and kappa and lambda light chains

A

isotypes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

antibody heterogeneity: species-specific variations in the constant domains of heavy or light chains; different alleles of heavy chains

A

allotypes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

antibody heterogeneity: variation in the variable region; produced by a single clone of cells

A

idiotypes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

links multiple monomers of IgM and IgA

A

joining (J) chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

predominant serum antibody, approximately 75% of immunoglobulins in the blood
only Ig that crosses placenta
produced in secondary (anamnestic) antibody response

A

IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

IgG subclasses

A

IgG1, IgG2, IgG3, IgG4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

IgG subclasses that activate the classical complement pathway

A

IgG1, IgG2, IgG3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

five monomers linked together by a J chain and interchain disulfide bonds
10% of total serum Ig
first antibody produced against an immunogen
produced in high levels in the primary response
best activator of the classical pathway of complement only one molecule is required

A

IgM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

2 forms of IgA

A

serum IgA
secretory IgA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

IgA: single Ig molecule; antigen clearance and immune regulation

A

serum IgA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

IgA: dimer held together by a J-chain; block attachment of viruses, bacteria and toxins to host cells

A

secretory IgA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

2 subclasses of IgA

A

IgA1 and IgA2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

accounts for 15-20% of total serum antibody

A

IgA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

primarily a cell membrane surface component of beta-lymphocytes
short half-life (2-3 days)

A

IgD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

responsible for allergic (type 1 hypersensitivity) reactions
Fc portion binds to receptors on mast cells and basophils
once attached to mast cells, binding to an allergen triggers degranulation of the cell and release of allergic mediators, such as histamine and leukotrienes
elevated concentrations are often found during parasitic infections

A

IgE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

identical antibodies that are produced from a single clone of plasma cells
found in individuals with multiple myeloma
produced in industry by fusing an antigen-sensitized, splenic beta-lymphocyte with non secreting myeloma cell thus creating an immortal cell line that secretes an antibody of a single idiotype

A

monoclonal antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

quantitation on antibodies

A

radial immunodiffusion
nephelometry
turbidimetry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

immune system: responsible for non specific response
phagocytosis of invaders
present immunogens to T helper cells, the first step in an immune response
release cytokines that affect other cells’ activities

A

myeloid cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

myeloid cells in the peripheral blood

A

monocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

myeloid cells in the tissue

A

macrophage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

macrophages have these on their surface

A

major histocompatibility complex class II
complement receptors
antibody Fc receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

granulocytes: 60-70% of WBCs in circulation; phagocytosis and contributes to inflammatory response

A

neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

granulocytes: 1-3% of circulating wbcs; mediate IgE allergic response

A

eosinophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

granulocytes: 0-1% of circulating wbcs, has receptors for IgE and granules responsible for allergic reactions

A

basophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

20-40% of circulating wbcs

A

lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

20% of circulating lymphocytes
express surface molecules such as CD19 and CD20
mature in the bone marrow

A

b cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

b cells differentiate into:

A

plasma cells
memory b cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

produce antibody

A

plasma cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

80% of circulating lymphocytes
express surface molecules such as cd2 and cd3
lyse host cells infected with viruses and tumor cells and also produce lymphokines

A

t cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

slightly larger than t or b cells and have cytoplasmic granules

A

nk cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

present antigens to T cells

A

dendritic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

dendritic cells in the dermis and squamous epithelia

A

langerhans cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

granulocyte resembling basophil that contains many chemicals that affect the immune response

A

mast cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

soluble protein molecules secreted by one cell type that affect other cells turn on genes in target cells

A

cytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

antiviral proteins that inhibit viral replication and activate NK cells
produced by virally-infected cells

A

interferon-alpha and -beta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

antiviral effects, activate macrophages and NK cells, stimulates b cells to produce antibodies
produced by TH1 cells

A

interferon-gamma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

produced by macrophages, lymphocytes, and NK cells when encountering bacteria, viruses, tumor cells, toxins, and complement protein C5a

A

tissue necrosis factor-alpha

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

produced by cd4 and cd8 positive cells after exposure to a specific antigen

A

tnf-beta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

cytokine
cellular source: macrophages, b cells, fibroblasts
primary targets: t cells, b cells, macrophages, endothelium

A

IL-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

cytokine
cellular source: t cells
primary targets: t cells

A

IL-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

cytokine
cellular source: t cells
primary targets: stem cells

A

IL-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

cytokine
cellular source: t cells
primary targets: b cells, t cells

A

IL-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

cytokine
cellular source: t cells
primary targets: b cells

A

IL-5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

cytokine
cellular source: t cells, b cells, fibroblasts, macrophages
primary targets: b cells, hepatocytes

A

IL-6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

cytokine
cellular source: bone marrow, stromal cells
primary targets: pre-b cells, t cells

A

IL-7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

cytokine
cellular source: monocytes
primary targets: fibroblasts

A

IL-8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

cytokine
cellular source: t cells
primary targets: t cells, mast cells

A

IL-9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

cytokine
cellular source: t cells
primary targets: TH1 cells

A

IL-10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

cytokine
cellular source: macrophages, mast cells, lymphocytes
primary targets: macrophages, granulocytes, tissue cells

A

TNF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

cytokine
cellular source: leukocytes, epithelia, fibroblasts
primary targets: tissue cells

A

INF-alpha

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

cytokine
cellular source: fibroblasts, epithelia
primary targets: tissue cells, leukocytes

A

INF-beta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

cytokine
cellular source: T cells, NK cells, epithelia, fibroblasts
primary targets: leukocytes, tissue cells, TH2 cells

A

INF-gamma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

produced by macrophages, B cells, and other cell types
activates T helper cells, increase number of B cells, activates vascular endothelium, causes fever and acute phase protein synthesis and induces T cells to produce lymphokines

A

IL-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

produced by T helper cells
causes proliferation of activated t and b cells

A

IL-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

produced by activated T cells
causes increases in the number of mast cells in skin, spleen and liver

A

IL-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

produced by activated T cells
induces proliferation of T cells and class switching from IgM to IgG1 and IgE

A

IL-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

primary lymph tissues of adults

A

bone marrow and thymus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

secondary lymphoid organs: in the lymph nodes, ___ migrate to the cortex and ___ to the paracortex

A

b cells
t cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

secondary lymphoid organs: in the lymph nodes: ____ there are many small b cells, and after stimulations becomes ____

A

primary follicle
secondary follicle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

secondary lymphoid organs: has small and large lymphocytes, blast cells, macrophages and dendritic cells

A

germinal center

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

secondary lymphoid organs: contains plasma cells and large lymphocytes

A

medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

secondary lymphoid organs: filters blood, contains both t and b cells

A

spleen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

secondary lymphoid organs: found in submucosa in gastrointestinal tract and urogenital tract, these surfaces interact with the environment and can begin the immune response early

A

mucosal associated lymphoid tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

specialized MALT found in the lower ileum

A

Peyer’s patch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

cell surface markers that allow immune cells to distinguish self from nonself
first described on white blood cells and are coded for by genes in the MHC located on the chromosome six

A

human leukocyte antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

MHC found on nearly every nucleated cell surface
antigen presenting cells with MHC I molecules present antigens to CTLs

A

class I loci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

class I loci

A

HLA-A
HLA-B
HLA-C
HLA-E
HLA-F
HLA-G
HLA-I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

molecules located on the surface of monocytes, macrophages, b cells, activated t cells, dendritic cells, langerhans cells and some epithelial cells
antigen presenting cells with MHC II molecules present antigen to T helper cells
HLA-DM, HLA-DO, HLA-DP, HLA-DQ, HLA-DR

A

class II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

complement proteins, TNF-alpha and beta, and other proteins not associated with cell membrane surfaces

A

class III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

combination of inherited HLA alleles

A

combination of inherited HLA alleles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

true or false: transplants last longer if the HLA antigens from the recipient and the donor are closely matched

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

true or false: although poor response to platelet transfusion is multifactorial, antibodies to class I HLA antigens are the primary cause of immune-mediated platelet transfusion refractoriness

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

true or false: 46 haplotypes are a genotype

A

false, only 2 (one from each parent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

true or false: HLA loci are polymorphic and recombination is rare. HLA inheritance patterns can exclude fathers with approximately 99%

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

HLA antigen associated with ankylosing spondylitis

A

HLA B-27

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

involved in nonspecific response by attachment to damaged epithelium, migration into tissue chemotaxis, phagocytosis, and digestion of target cells, increased metabolism, and degranulation

A

PMNs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

defect in oxidative pathway (respiratory pathway) that phagocytes use to create hydrogen peroxide, which is used to kill bacteria

A

chronic granulomatous disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

granules contain acid phosphatase, peroxidase, histamine and several other types of molecules
clearing immune complexes, limiting inflammatory reactions, protein in granules toxic to parasites

A

eosinophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

release substances that mediate immune reaction
causing increased vascular permeability, smooth muscle contraction, chemotaxins for phagocytes, increased inflammatory response

A

mediator cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

mediator cells

A

mast cells
basophils
platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

degranulate when membrane-bound IgE binds an allergen or by non immunologic mechanisms such as surgical incisions, heat and skin or mucous membrane infection

A

mast cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

amplify the reactions that start with the mast cells at the site of entry of the antigen
play a role in anaphylactic reactions

A

basophil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

mononuclear phagocyte system

A

alveolar macrophages
splenic macrophages
Kuppfer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

sequenced evens following tissue damage that protect the host from foreign invaders and attempt to minimize tissue damage
increased vascular permeability which then causes fluid to move from the circulation to the space around the injury site

A

inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

PMNs move between the endothelial cells to the site of tissue damage

A

diapedesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

components on of the complement system are synthesized by the liver, except ___, which is synthesized in the epithelial cells of the intestines

A

C1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

complement system: five proteins unique to the classical pathway

A

C1q
C1r
C1s
C4
C2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

complement system: three proteins unique to the alternative pathway

A

factor B
factor D
properdin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

complement system: six proteins common to both pathways

A

C3
C5
C6
C7
C8
C9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

activation of the complement: classical pathway

A

immune complexes, require one IgM or two IgG molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

activation of the complement: alternative pathway

A

antibody-independent, microbial components such as lipopolysaccharide, polysaccharide, teichoic acid, and peptidoglycan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

activation of the complement: lectin pathway

A

binding of mannose-binding lectin to mannose residues on glycoproteins or carbohydrates on the surface of microorganisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

true or false: C4a, C5a, C6a causes basophils and mast cells to release histamine and also cause smooth muscle contraction and increased vascular permeability

A

false, C3a, C4a, C5a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

true or false: C3a adheres to immune complexes and surfaces of substances to facilitate clearing of these molecules

A

false, C3b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

true or false: if C3b is attached to a cell, phagocytosis is enhanced

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

true or false: C5b is an anaphylatoxin and induces the migration of neutrophils and monocytes to the site

A

false, C5a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

true or false: cell lysis through the formation of the membrane attack complex

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

components of the membrane attack complex (MAC)

A

C5 through C9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

C1 inhibitor combines with C1r and C1s to block ___

A

C1 activities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

deficiency in C1INH
autosomal dominant disease
unregulated classical pathway activation resulting in vascular permeability, and swollen mucous membranes in airways which can become blocked

A

hereditary angioehema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

removes a single amino acid from C4a, C3a and C5a, rendering them useless as anaphylatoxin

A

anaphylatoxin inactivator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

MAC inhibitors

A

S protein binds to C5b-C7 complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

CRI binds C3b and C4b and inhibits the amplification loop

A

complement receptor type I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

acute-phase reactants: activate the classical pathway of complement and can also bind to NK cells and monocytes, stimulating them to target tumor cells
may also be increased during acute coronary heart diseases

A

c-reactive proteins (crp)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

acute-phase reactants: removes free hemoglobin from circulation

A

haptoglobin

106
Q

acute-phase reactants: converted to fibrin to heal the injury

A

fibrinogen

107
Q

acute-phase reactants: family of serine protease inhibitors synthesized in the liver, deficiency causes premature loss of elasticity in the lung and liver damage

A

alpha-1 antitrypsin

108
Q

acute-phase reactants: principal copper-transport protein, vital in aerobic energy production, collagen formation, and protection against superoxide ions

A

ceruloplasmin

109
Q

deficiency of ceruloplasmin

A

wilson disease

110
Q

acute-phase reactants: protease inhibitor, complexes are phagocytized by macrophages and fibroblasts

A

alpha-2 macroglobulin

111
Q

phagocytic cells that process antigen and express it on the cell surface associated with MHC class I and II molecules

A

monocyte/macrophages
dendritic cells

112
Q

nonphagocytic cells that attach to antigens in their native form, process antigens and express them on their surface associated with MHC II molecules

A

b cells

113
Q

true or false: b cell antigen receptor is monomeric IgM and IgG

A

false, IgM or IgD

114
Q

b cell surface receptors have two identical antigen-binding pockets

A

Fab portion

115
Q

t cell receptor consists of two non identical _____

A

peptides
cd3

116
Q

t helper cells have ____ on their surface that interacts with MHCII on the antigen presenting cell

A

cd4

117
Q

ctls have ___ on their surface that interacts with ___ on the antigen presenting cell

A

cd8
mhcI

118
Q

mediated by TH1 cells
monocytes and macrophages are stimulated by cytokines from TH1 cells
ctls are activated by cytokines from TH1 cells and then destroy targets by cell-to-cell contact, main function is to destroy infected cells
nk cells kill target cells without being previously sensitized

A

cell-mediated immunity

119
Q

subset of T helper cells that secrete cytokines that activate other cells involved in the response

A

TH1 cells

120
Q

b cell activation begins when antigen binds to antibody on B cell surface and the antigen is internalized and linked to an MHC II molecule on the cell’s surface

A

humoral mediated immunity

121
Q

antibodies can be produced that recognize an unlimited number of antigens but there are a limited number of B cells
due to recombination events that occur during b cell maturation

A

antibody diveristy

122
Q

produce antibodies with the same specificity of antibodies that were on the surface of the b cell

A

plasma cells

123
Q

produced when host first encounters antigen
no antibody is produced for about 5-7 days
during this time, the host is producing plasma cells that will secrete antibodies
antibody production starts, slowly peaks, levels off then declines

A

primary antibody response

124
Q

first antibody produced during the primary antibody response

A

IgM

125
Q

produced after the host has previously been exposed to an antigen
short lag phase (3-5 days)
higher antibody concentration
IgG produced due to class switching, and persists longer in circulation than IgM

A

secondary antibody response

126
Q

cytolytic effector cells can lyse antibody coated target cells if there is direct contact

A

antibody-dependent cell-mediated cytotoxicity

127
Q

occurs when an an individual produces antibodies or a t cell response to his/her own antigens
there is a loss of self-tolerance
antibody-cell surface component interaction > formation of autoantigen-autoantibody complexes > sensitization of t cells

A

autoimmune disease

128
Q

diseases and conditions associated with hla types: HLA-B8

A

graves disease
type I disease

129
Q

diseases and conditions associated with hla types: HLA-DR2

A

SLE
multiple sclerosis
hashimoto disease
myasthenia gravis

130
Q

diseases and conditions associated with hla types: HLA-DR3

A

sjogren syndrome
myasthenia gravis
SLE
graves disease
type I disease

131
Q

diseases and conditions associated with hla types: HLA-DR4

A

rheumatoid arthritis
type I diabetes
pemphigus vulgaris

132
Q

autoimmune theories: burnet postulated that when an error in self-recognition occurs during the fetal life and lymphocytes against an autoantigen are not destroyed, then autoantibodies are produced

A

forbidden-clone theory

133
Q

autoimmune theories: clones developed during fetal life are not stimulated by low doses of antigens. the ability to produce antibodies against higher doses of antigens is still preset

A

clonal energy

134
Q

autoimmune theories: some antigens are hidden from the immune system during fetal development. when the tissue is damaged, the “hidden cells” are exposed to the immune system and antibodies are produced against these cells

A

sequestered-antigen theory

135
Q

autoimmune theories: suppressor t cells control antibody production by b cells. if suppressor t cell exhibit decreased activity, then antibodies against autoantigens are produced

A

immunologic deficiency theory

136
Q

autoimmune theories: an individual can make antibodies or reactive t cells to an infectious agent that cross react with self-antigens

A

molecular mimicry

137
Q

autoimmune theories: a number of bacteria and viruses are known to non specifically stimulate b cells. if these b cells have activity against self antigens, an autoimmune disease

A

polyclonal b cell activation

138
Q

diagnostic tests for non-organ specific autoimmune diseases: associated with SLE, mixed connective tissue disease and rheumatoid arthritis

A

anti-nuclear antibodies (ANA)

139
Q

techniques used to detect ANA

A

agglutination
indirect immunofluorescence
enzyme immunoassay

140
Q

interpretation of indirect immunofluorescence results: evenly stains the nuclei and is associated with anti-dna antibodies and histones

A

diffuse or homogenous

141
Q

interpretation of indirect immunofluorescence results: stains the edge of the nuclei and is associated with anti-dna antibody and antibi-lamins (proteins found in the nuclear membrane) antibody

A

peripheral

142
Q

interpretation of indirect immunofluorescence results: numerous evenly distributed stained speckles within the nuclei associated with antibodies to extractable nuclear antigen-nucleanribonucleoprotein (anti-RNP) and anti-smith

A

speckled

143
Q

interpretation of indirect immunofluorescence results: stains two or three large areas within the nucleus and is associated with anti-RNP antibody

A

nucleolar

144
Q

interpretation of indirect immunofluorescence results: stains as a discrete speckled pattern due to anti-centromere antibody

A

centromere

145
Q

autoantibodies and associated disorders: centromere

A

CREST (calcinosis cutis, raynaud syndrome, esophageal hypomotility, sclerodactyly and telangiectasia) syndrome

146
Q

autoantibodies and associated disorders: dsDNA

A

found in SLE and low titers found in rheumatoid arthritis and sjogren syndrome

147
Q

autoantibodies and associated disorders: histone

A

drug-induced SLE

148
Q

autoantibodies and associated disorders: nuclear RNP

A

SLE and mixed connective tissue disease

149
Q

autoantibodies and associated disorders: Scl-70

A

scleroderma (systemic sclerosis)

150
Q

autoantibodies and associated disorders: Sjogren syndrome A (SSA [Ro])

A

sjogren syndrome and SLE

151
Q

autoantibodies and associated disorders: Sjogren syndrome B (SSA [LA])

A

sjogren syndrome and SLE

152
Q

autoantibodies and associated disorders: Sm

A

diagnostic for SLE (high specificity) if present but low sensitivity

153
Q

diagnostic tests for non-organ specific autoimmune diseases: anti-antibody, typically IgM, that binds the Fc portion of IgG; usually detected by latex agglutination, positive for 75% of patients with rheumatoid arthritis and also noted in chronic hepatitis, SLE and syphilis

A

rheumatoid factor (RF)

154
Q

diagnostic tests for non-organ specific autoimmune diseases: proteins that reversibly precipitates at 4degC, and associated with autoimmune diseases such as vasculitis, glomerulonephritis, SLE, RA and sjogren syndrome

A

cryoglobulins

155
Q

chronic, non infectious inflammatory disease involving many organs
more likely to occur in women than men and in black than whites
tissue injury is caused by autoantibodies and immune complexes deposited in the tissues
depressed suppressor T cell function allows production of antibodies against self
symptoms include fever, weight loss, malaise, weakness, arthritis, skin lesions, photosensitivity, butterfly rash, renal disease, pericarditis, seizures, ocular changes, pancreatitis, and small-vessel vasculitis

A

SLE

156
Q

chronic, non infectious, systemic inflammatory disease that primarily affects the joints
women are affected 2-3 times more often than men
due to production of IgM antibodies against IgG in the synovium > immune complexes form > activates complement > inflammatory response proceeds and damages the synovium > attract neutrophil and macrophages to the joint that degranulate and contribute to tissue destruction
symptoms: fatigue, weight loss, weakness, mild fever, anorexia, morning stiffness, joint pain, vasculitis, rheumatoid nodules
lab: elevated ESR, elevated CRP, positive RF, cryoglobulins and sometimes ANAs, synovial fluid is cloudy with a WBC count between 5000-20,000/microliters, elevated protein, poor mucin clot development, decreased complement and positive RF

A

rheumatoid arthritis

157
Q

an inflammation of the salivary and lacrimal glands causing dryness of the mouth and eyes
lab: polyclonal hypergammaglobulinemia, autoantibodies against the salivary glands and positive RF, ANA (speckled or diffuse pattern), anti-SSA and anti-SSB

A

sjogren syndrome

158
Q

increased rate of RBC destruction
results in a normocytic, normochromic anemia
autoantibody is directed against RBC antigens
lab: positive direct antiglobulin test and sometimes cold agglutinins

A

autoimmune hemolytic anemia

159
Q

humoral and cellular immunity are activated and destruction of normal thyroid tissue leads to hypothyroidism, loss of thyroid function and low levels of thyroid hormone in the blood
antithyroid antibodies detected include antithyroglobulin, antithyroid peroxidase (microsomal antigen), and second colloid antigen (CA-2)

A

hashimoto disease

160
Q

hyperplasia and diffuse goiter caused by autoantibody reacting with thyroid receptor on cells that overstimulates the thyroid gland
autoantibody mimics the activity of thyroid stimulating hormone
thyrotoxicosis results from overstimulation; both free and total T3 and T4 are elevated and TSH is decreased
symptoms: exophthalmos and infiltrative dermopathy

A

graves disease

161
Q

neuromuscular disease in which the nerve muscle do not function normally
most patients exhibit antibodies to acetylcholine receptors
autoantibodies block nerve impulses and can initiate damage to neurons

A

myasthenia gravis

162
Q

considered a chronic progressive inflammatory disease with demyelinization of the nerves
active lesion contains CTLs, helper T cells and macrophages
most patients have increased IgG concentrations in the cerebrospinal fluid
oligoclonal bands in CSF on high resolution electrophoresis are also indicative

A

multiple sclerosis

163
Q

islet cell destruction in the pancreas results in insulin-dependent
autoantibodies and CTLs reactive against pancreatic beta cells produce marked atrophy and fibrosis of the islet cells > insulin deficiency
viruses can trigger autoantibody production by molecular mimicry

A

type I diabetes

164
Q

overreactive immune responses to innocuous substances on re-exposure that can result in tissue damage
involve humoral (types I-III) and cell-mediated (IV) responses

A

hypersensitivity

165
Q

classified as an immediate hypersensitivity reaction because it occurs within minutes after re-exposure to an allergen
after the first exposure, basophils and mast cells are sensitized with IgE, upon second exposure, IgE binds to a specific allergen and chemical mediators are released from those cells (degranulation), which causes allergic symptoms

A

type I hypersensitivity reaction

166
Q

systemic form of the type I hypersensitivity
shock or edema of the upper respiratory tract

A

anaphylaxis

167
Q

type I hypersensitivity mediators: causes contraction of bronchioles and smooth muscle of blood vessels, increases capillary permeability, increases mucus secretion int he airway

A

histamine

168
Q

type I hypersensitivity mediators: cause vasodilation and increased vascular permeability

A

prostaglandins

169
Q

type I hypersensitivity mediators: erythema and wheal formation, 30-1000 times the ability of histamine to cause bronchospasm and also stimulate mucus secretion in the airways

A

leukotrienes

170
Q

methods used to measure total serum IgE levels

A

competitive radioimmunosorbent test (RIST)
non competitive RIST
double-antibody radioimmunoassay (RIA)
sandwich enzyme-linked immunosorbent assay (ELISA)

171
Q

due to IgG or IgM antibodies directed against cell surface antigens
immediate hypersensitivity reaction
antibody-mediated tissue damage: PMNs bind to antibody-sensitized cells and destroy the cells by phagocytosis or antibody-dependent cellular cytotoxicity reaction
complement-mediated cell lysis: antibody-antigen complex on cell surface activates the complement pathway to cause lysis
incompatible blood transfusion
damage to sensitize tissue cells causes inflammation which, in turn causes damage to normal tissue cells

A

type II hypersensitivity

172
Q

immune complex reactions, immune complexes are deposited on tissue causing inflammation
immediate hypersensitivity reaction
circulating immune complexes
SLE, RA, serum sickness, arthus reaction

A

type III hypersensitivity

173
Q

two sites where immune complexes are often deposited in type III hypersensitivity

A

heart valves
renal glomerulus

174
Q

type III hypersensitivity: an allergen injected intradermally

A

arthus reaction

175
Q

type III hypersensitivity: patients develop antibodies against heterologous serum proteins

A

immune complex disorders

176
Q

type III hypersensitivity: immune complexes are deposited on renal glomeruli, causing inflammation of the kidney and possibly renal failure

A

glomerulonephritis

177
Q

type III hypersensitivity: inflammation of the blood vessel wall

A

vasculitis

178
Q

caused by soluble factors or lymphokines released by T cells > antibody and complement are not involved in this reaction
lymphokines are produced by T cells
these chemicals attract macrophages that become activated, causing them to degranulate
as more macrophages arrive at the site, ulceration and necrosis occur

A

type IV hypersensitivity

179
Q

subcutaneous injection of tuberculosis antigen is sued as a diagnostic skin test
swelling occurring at the site within 24-72 hours indicates previous infection

A

tuberculin-type hypersensitivty

180
Q

allergens from poison ivy and poison oak cause sensitization resulting in edema in the skin with the formation of microvesicles and itching on subsequent exposure

A

contact sensitivity (dermatitis)

181
Q

marked deficiency of all classes of Ig is detected after about 6 months of age
recurrent, life-threatening infections occur with encapsulated influenzae, manifested as pneumonia, sinusitis, bronchitis, otitis, furunculosis, meningitis, and septicemia
b cells are markedly decreased or absent

A

bruton x-linked agammaglobulinemia

182
Q

x-linked genetic disease
serum IgM is increased; IgG and IgA are markedly decreased or absent
defect in CD40 ligand on T helper cells prevents class switching from IgM to IgG, IgA or IgE
affected individuals are prone to respiratory tract infections, often have autoantibodies to platelets, red blood cells and neutrophils

A

hyper IgM syndrome

183
Q

patients present with small amounts or absence of serum and secretory IgA
usually caused by a genetic defect or by drugs (phenytoin and penicillin)
anaphylaxis may result if IgA is administered to someone with this deficiency

A

selective IgA deficiency

184
Q

autosomal recessive disorder that presents with ataxia, telangiectasia, recurrent sinopulmonary infections, a high incidence of malignancy, and variable immune defects
typically present with an IgA and sometimes IgE deficiency
defect in a kinase gene that regulates the cell cycle
b and t helper cells are affected

A

ataxia-telangiectasia

185
Q

because T cells are involved in both humoral and cell mediated responses, individuals with ____ can have a severe combined immunodeficiency

A

T helper deficiencies

186
Q

hypocalcemic tetany, due to underdevelopment of the thymus and heart disease
immune defect is variable, from slight decrease in T cells to no T cells in the bloodstream
very susceptible to opportunities infections and have a poor prognosis

A

congenital thymic hypoplasia
digeorge syndrome

187
Q

group of diseases with different causes, that affect T and B cell function, resulting in a suppression of humoral and cell mediated immune responses

A

severe combined immune deficiency

188
Q

absence of these enzymes causes an accumulation of nucleotide metabolites in all cells which is particularly toxic to T and B cells
very low number of T cells is present, and children often have an underdeveloped thymus-lack of tonsil or lymph nodes, hypogammaglobulinemia, and lymphopenia

A

adenosine deaminase or purine nucleotide phosphorylase

189
Q

with an mhc class II deficiency, t helper cells fail to develop
patients present with hypogammaglobulinemia and no cell-mediated immune response
mhc class I deficiency is less severe
loss of ctls and response to intracellular pathogens

A

bare lymphocyte syndrome

190
Q

defect prevents t helper cells from delivering lymphokines to b cells, macrophages and other target cells
patients demonstrate eczema, thrombocytopnenic purpura, and increased risk of infection
platelets are small and defective

A

wiskott-aldrich syndrome

191
Q

protein involved with cytoskeletal reorganization necessary for delivering cytokines

A

wiskott aldrich syndrome protein

192
Q

complement deficiencies: patients with defects in early ______ such as factor D and properdin, are susceptible to infections by Neisseria meningitidis

A

alternative complement proteins

193
Q

complement deficiencies: patients with a ______ have the most severe clinical manifestations

A

c3 defects

194
Q

decline in serum immunoglobulins during the first few months of life
individuals eventually produce normal amounts of immunoglobulins

A

transient hypogammaglobulinemia

195
Q

certain viruses impair the function of the immune systems

A

human immunodeficiency virus
epstein barr virus
cytomegalovirus

196
Q

tremendous amounts of several classes of immunoglobulins to several specific antigens are produced, resulting in a broad spike in the gamma region on serum protein electrophoresis

A

polyclonal hypergammaglobulinemia

197
Q

causes of polyclonal hypergammaglobulinemia

A

infectious diseases
inflammatory responses
liver disease

198
Q

malignant transformation of a clone of b cells that produce identical antibodies
narrow peak on serum protein electrophoresis

A

monoclonal hypergammaglobulinemia

199
Q

lymphoproliferative disease in which plasma cells produce a high concentration of immunoglobulin
approximately 50% of patients have Bence Jones proteins
weakness, anorexia, weight loss, skeletal destruction, plasma cell infiltrate in bone marrow

A

multiple myeloma

200
Q

light chain fragments

A

bence jones proteins

201
Q

diagnostic of multiple myeloma, waldenstrom macroglobulinemia, chronic lymphocytic leukemia or lymphoma
immunoglobulin type determination is necessary for diagnosis and prognosis

A

monoclonal immunoglobulins (m protein)

202
Q

uncontrolled proliferation of a clone of b cells that synthesize a homogenous IgM
cause unknown
hyperviscosity of plasma causes heart failure, headache dizziness, partial or total loss of vision, bleeding and anemia
weakness, fatigue, headache and weight loss
lab: a spike in the beta or gamma region on serum protein electrophoresis, increased plasma viscosity, and abnormal accumulation of lymphoid cells in the bone marrow and tissues

A

waldenstrom macroglobulinemia

203
Q

non structural protein that becomes insoluble after an alteration in its secondary structure

A

amyloid protein

204
Q

monoclonal plasma cell disorder in which abnormal immunoglobulin or bence jones protein or less commonly heavy chain fragment is produced
insoluble proteins are deposited in some of the tissues: skin, liver, nerves, heart, kidney
results in progressive loss of organ function
lab: frequent abnormalities of serum Ig and presence of bence jones proteins

A

primary amyloidosis

205
Q

transfer of tissue from one site to another within an individual

A

autograft

206
Q

transfer of tissue between genetically identical individuals

A

isograft (syngraft)

207
Q

transfer of tissue between two genetically non identical individuals of the same species

A

allograft

208
Q

transfer of tissue between two individuals of different species

A

xenograft

209
Q

revascularization and healing lead to a repaired site in about 2 weeks

A

graft acceptance

210
Q

first time a graft is encountered, the immune system attacks and ultimately destroys (rejects) the nonself tissue
occurs 10-14 days after transplantation

A

first set rejection

211
Q

the second time non self tissue with the same or similar antigens is encountered
rejected within 6 days

A

second set rejection

212
Q

clinical indications of graft rejection: occurs within 24 hours of transplantation
rejection is caused by a pre-existing antibody to antigens on the grafted tissue
tissue never becomes vascularized
caused by ABO blood group antibodies and MHC class I antibodies

A

hyperacute rejection

213
Q

clinical indications of graft rejection: occurs within weeks of transplantation
due to cell-mediated response
histopathology reveals massive infiltration of lymphocytes and macrophages

A

acute rejection

214
Q

clinical indications of graft rejection: occurs months to years after transplantation
mechanisms of rejection include both humoral-mediated and cell-mediated immunity

A

chronic rejection

215
Q

abnormal mass of tissue that results from the uncontrolled growth of normal cells even after the growth stimulus is removed

A

neoplasm

216
Q

typically a mild and non progressive tumor that pushes aside normal tissue, but does not invade it, as the tumor expands

A

benign tumor

217
Q

generally consisting of poorly differentiated cells that grow rapidly and invade surrounding tissue, robbing the normal tissue of nutrients

A

malignant tumor

218
Q

secondary tumor derived from a malignant primary tumor

A

metastatic tumor

219
Q

intracellular proteins expressed on the surface of a tumor due to interaction with MHC class I and II moleculues

A

tumor-specific peptides

220
Q

occurs when macrophages come in close contact with tumor cells

A

macrophage-mediated cytotoxicity

221
Q

kills those cells with mutations leading to decreased MHC class I products expressed on their surfaces

A

NK cells

222
Q

antibodies can be produced to antigens found on the surface of tumor cells, which then can be lysed by complement activation or antibody dependent cellular cytotoxicity reactions involving NK cells, PMNs and macrophages

A

humoral-mediated immunity

223
Q

activates t cells, b cells and nk cells and induces a fever

A

IL-1

224
Q

destroys tumor cells

A

TNF alpha

225
Q

produced by activated t cells and nk cells

A

INF-gamma

226
Q

glycoproteins found in small amounts in normal serum but elevated in certain types of cancers
used to screen for cancer but more commonly are used to monitored therapeutic response or to determine tumor burden

A

tumor markers

227
Q

used in management of gastrointestinal tumors (colon cancers) and adenocarcinomas of the colon, pancreas, liver and lungs
can also be found in inflammatory bowel disease, ulcerative colitis, crohn disease, polyps tumors of the GI tract, and cigarette smokers

A

carcinoembryonic antigen (CEA)

228
Q

produced during embryonic and fetal development
high in patients with hepatocellular carcinoma, hepatoblastoma, testicular and ovarian cancer
can also be elevated in viral hepatitis, cirrhosis and ulcerative chelitis
temporary marker for monitoring cancer therapy

A

alpha fetoprotein (AFP)

229
Q

composed of two subunits: alpha and beta
found in serum and urine during pregnancy
may be produced by neoplastic cells of testicular cancer and various other tumors
levels are useful in evaluating patients with gestational trophoblastic disease, testicular tumors and ovarian germ cell tumors

A

human chorionic gonadotropin (hCG)

230
Q

glycoprotein that dissolves seminal gel formed after ejaculation
normal prostate tissue contains this but it is present in extremely low amounts in blood
increased in prostrate cancer, benign prostatic hypertrophy, and acute or chronic prostatitis
levels correlate with prostrate size, stage of prostate cancer and response to treatment
used to screen for prostate cancer in conjunction with a digital rectal examination

A

prostate specific antigen (PSA)

231
Q

antigen-antibody interactions: positively charged portions of one molecule are attracted to negatively charged portions of another molecule
affected by the pH and ionic strength of the environment
increases as the two molecules get closer together

A

electrostatic force or ionic bonding

232
Q

antigen-antibody interactions: binds to an electronegative atom such as oxygen or nitrogen
weak bond, but it contributes greatly to the antigen-antibody interaction
maximum binding strength occurs below 37degC

A

hydrogen bonding

233
Q

antigen-antibody interactions: attraction between non polar groups
non polar groups tend to aggregate to reduce surface area, and this increased the strength of the bond

A

hydrophobic bonding

234
Q

antigen-antibody interactions: a weak, attractive force between an electron orbital of one atom and the nucleus of another atom

A

van der waals force

235
Q

antigen-antibody interactions: strength of interaction between an antibody binding site and a single epitope

A

affinity

236
Q

antigen-antibody interactions: describes whether the antigen-antibody complex is highly complementary, and therefore would not bind readily

A

affinity constant

237
Q

antigen-antibody interactions: affinity for multivalent antigens and multiple antibodies to combine; the extent of bindings capacity
greater than the cumulative affinity constants for all antigen-antibody pairs

A

avidity

238
Q

antigen-antibody interactions: antibody’s greatest affinity for a particular antigen

A

specificity

239
Q

antigen-antibody interactions: occurs when the antibody combines with an antigen that is structurally similar to the immunogen that stimulated the antibody production or the antigen that the antibody has the greatest affinity

A

cross reactivity

240
Q

assays involving antibody-antigen reactions

A

immunoassays

241
Q

soluble antigen and soluble antibody reacts to form an insoluble product, such as gel diffusion, radial immunodiffusion, immunoelectrophoresis, immunofixation, nephelometry and turbidity

A

precipitation reaction

242
Q

soluble antibody reacts with insoluble antigen or soluble antigen reacts with insoluble antibody; reactants are made insoluble by combining with latex particles, rbcs, dyes, liposomes

A

agglutination

243
Q

antigen-antibody interactions: a label producing a measurable end product is attached to an antibody or antigen; labels include fluorochromes, enzymes, chemiluminescent molecules, and radionuclides

A

labeled reaction

244
Q

precipitation reactions: maximum precipitation occurs when the concentration of the antigen and antibody are about equal

A

zone of equivalence

245
Q

precipitation reactions: occurs when excess amount of antibody is present, and the antigen and antibody do not combine to form precipitates - the complexes remain soluble; results in a false negative result

A

prozone

246
Q

precipitation reactions: occurs when excess amount of antigen is present, and the antigen and antibody do not combine to form precipitates - the complexes remain soluble; results in a false negative result

A

postzone

247
Q

types of precipitation reactions: passive diffusion of soluble antigen and antibody

A

fluid-phase precipitation

248
Q

measurement of light transmitted through a suspension of particles; formation of immune complexes decreases the amount of light passing through a suspension
the more immune complexes are formed, and the larger they are, the greater the decrease in light able to pass through

A

turbidimetry

249
Q

direct measure of light scattered by particles suspended in solution
scattering of light is proportional to the size and the amount of immune complexes formed

A

nephelometry

250
Q

types of precipitation reactions: antigen and antibody diffuse through the agar gel and precipitate when they reach the zone of equivalence; molecular size determines the speed of travel through the gel

A

precipitation reactions in agar gel

251
Q

types of precipitation reactions: antigen and antibody are placed in wells in the gel and diffuse towards each other, when optimum concentrations are met, a precipitate line forms
can be used to determine if a specific antibody is present in serum

A

double immunodiffusion (oachterlon) technique

252
Q

types of precipitation reactions: on an agar gel plate or slide, antigen is added to one well, and antibody is added to another well
an electric current accelerates the movement of the antigen and antibody toward each other, resulting in precipitation sooner than if an electric current is not applied
can be used to detect antibody to infectious agents and microbrial antigens

A

contercurrent immunoelectrophoresis

253
Q

serum urine, or CSF, is electrophoresed
antisera contained in a cellulose acetate strip are then placed on top of the electrophoresis gel
the antibodies diffuse into the electrophoresis
detects the presence of an immunoglobulin in serum or urine

A

immunofixation electrophoresis

254
Q

used to quantify antigens
antigens are electrophoresed in agar-containing antibody
a pH is selected so that the antibodies are immobile
antibody and antigen combine to form precipitates in the shape of a rocket
height is proportional to the concentration of antigen in the specimen

A

rocket immunoelectrophoresis

255
Q

occurs when particles in suspension clump together due to antibody-antigen interaction
uses an antigen or antibody attached to a particle (insoluble)

A

agglutination

256
Q

antibodies that participate in agglutination reaction

A

IgM
IgG

257
Q

this method uses antigens naturally occurring on a particle to demonstrate agglutination

A

direct agglutination

258
Q

naturally occurring process in which in virus will agglutinate RBCs by binding to surface receptors

A

viral agglutination

259
Q

technique in which soluble antigen is attached to a particle, producing agglutination with specific soluble antibody

A

passive agglutination

260
Q

a technique in which an antibody is attached to a particle, producing agglutination with a specific soluble (antigen)

A

reverse passive agglutination

261
Q

sometimes used to detect antibody in patient sera
serum is mixed with a specific known antigen
if antibody to the antigen is present, immune complexes forms
complement is added, and if an immune complex is present, it will bind the complement

A

complement fixation

262
Q
A